419 related articles for article (PubMed ID: 16883501)
1. [Memantine and Complex Regional Pain Syndrome (CRPS): effects of treatment and cortical reorganisation].
Sinis N; Birbaumer N; Schwarz A; Gustin S; Unertl K; Schaller HE; Haerle M
Handchir Mikrochir Plast Chir; 2006 Jun; 38(3):164-71. PubMed ID: 16883501
[TBL] [Abstract][Full Text] [Related]
2. Memantine treatment of complex regional pain syndrome: a preliminary report of six cases.
Sinis N; Birbaumer N; Gustin S; Schwarz A; Bredanger S; Becker ST; Unertl K; Schaller HE; Haerle M
Clin J Pain; 2007; 23(3):237-43. PubMed ID: 17314583
[TBL] [Abstract][Full Text] [Related]
3. Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome.
Correll GE; Maleki J; Gracely EJ; Muir JJ; Harbut RE
Pain Med; 2004 Sep; 5(3):263-75. PubMed ID: 15367304
[TBL] [Abstract][Full Text] [Related]
4. Complex regional pain syndrome-like symptoms during herpes zoster.
Berry JD; Rowbotham MC; Petersen KL
Pain; 2004 Jul; 110(1-2):e1-12. PubMed ID: 15275746
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of ketamine in anesthetic dosage for the treatment of refractory complex regional pain syndrome: an open-label phase II study.
Kiefer RT; Rohr P; Ploppa A; Dieterich HJ; Grothusen J; Koffler S; Altemeyer KH; Unertl K; Schwartzman RJ
Pain Med; 2008 Nov; 9(8):1173-201. PubMed ID: 18266808
[TBL] [Abstract][Full Text] [Related]
6. The motor system shows adaptive changes in complex regional pain syndrome.
Maihöfner C; Baron R; DeCol R; Binder A; Birklein F; Deuschl G; Handwerker HO; Schattschneider J
Brain; 2007 Oct; 130(Pt 10):2671-87. PubMed ID: 17575278
[TBL] [Abstract][Full Text] [Related]
7. Continuous brachial plexus blockade in combination with the NMDA receptor antagonist memantine prevents phantom pain in acute traumatic upper limb amputees.
Schley M; Topfner S; Wiech K; Schaller HE; Konrad CJ; Schmelz M; Birbaumer N
Eur J Pain; 2007 Apr; 11(3):299-308. PubMed ID: 16716615
[TBL] [Abstract][Full Text] [Related]
8. Effects of NMDA receptor antagonist memantine on mismatch negativity.
Korostenskaja M; Nikulin VV; Kicić D; Nikulina AV; Kähkönen S
Brain Res Bull; 2007 May; 72(4-6):275-83. PubMed ID: 17452287
[TBL] [Abstract][Full Text] [Related]
9. [Use of memantine in progressive glaucoma. Case report].
Schröder A; Erb C
Klin Monbl Augenheilkd; 2002 Jul; 219(7):533-6. PubMed ID: 12195321
[TBL] [Abstract][Full Text] [Related]
10. A pilot double-blind treatment trial of memantine for alcohol dependence.
Evans SM; Levin FR; Brooks DJ; Garawi F
Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
[TBL] [Abstract][Full Text] [Related]
11. Effects of low-affinity NMDA receptor channel blockers in two rat models of chronic pain.
Medvedev IO; Malyshkin AA; Belozertseva IV; Sukhotina IA; Sevostianova NY; Aliev K; Zvartau EE; Parsons CG; Danysz W; Bespalov AY
Neuropharmacology; 2004 Aug; 47(2):175-83. PubMed ID: 15223296
[TBL] [Abstract][Full Text] [Related]
12. Patterns of cortical reorganization parallel impaired tactile discrimination and pain intensity in complex regional pain syndrome.
Pleger B; Ragert P; Schwenkreis P; Förster AF; Wilimzig C; Dinse H; Nicolas V; Maier C; Tegenthoff M
Neuroimage; 2006 Aug; 32(2):503-10. PubMed ID: 16753306
[TBL] [Abstract][Full Text] [Related]
13. Memantine. Merz.
Kilpatrick GJ; Tilbrook GS
Curr Opin Investig Drugs; 2002 May; 3(5):798-806. PubMed ID: 12090556
[TBL] [Abstract][Full Text] [Related]
14. Long-term functional outcome measures in corticosteroid-treated complex regional pain syndrome.
Bianchi C; Rossi S; Turi S; Brambilla A; Felisari G; Mascheri D
Eura Medicophys; 2006 Jun; 42(2):103-11. PubMed ID: 16767061
[TBL] [Abstract][Full Text] [Related]
15. Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study.
Schifitto G; Navia BA; Yiannoutsos CT; Marra CM; Chang L; Ernst T; Jarvik JG; Miller EN; Singer EJ; Ellis RJ; Kolson DL; Simpson D; Nath A; Berger J; Shriver SL; Millar LL; Colquhoun D; Lenkinski R; Gonzalez RG; Lipton SA; ; ;
AIDS; 2007 Sep; 21(14):1877-86. PubMed ID: 17721095
[TBL] [Abstract][Full Text] [Related]
16. A pilot open-label study of the efficacy of subanesthetic isomeric S(+)-ketamine in refractory CRPS patients.
Kiefer RT; Rohr P; Ploppa A; Nohé B; Dieterich HJ; Grothusen J; Altemeyer KH; Unertl K; Schwartzman RJ
Pain Med; 2008; 9(1):44-54. PubMed ID: 18254766
[TBL] [Abstract][Full Text] [Related]
17. Reduction of allodynia in patients with complex regional pain syndrome: A double-blind placebo-controlled trial of topical ketamine.
Finch PM; Knudsen L; Drummond PD
Pain; 2009 Nov; 146(1-2):18-25. PubMed ID: 19703730
[TBL] [Abstract][Full Text] [Related]
18. The chemical biology of clinically tolerated NMDA receptor antagonists.
Chen HS; Lipton SA
J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
[TBL] [Abstract][Full Text] [Related]
19. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse.
Parsons CG; Stöffler A; Danysz W
Neuropharmacology; 2007 Nov; 53(6):699-723. PubMed ID: 17904591
[TBL] [Abstract][Full Text] [Related]
20. [NMDA-receptor antagonist in pain therapy].
Weber C
Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Aug; 33(8):475-83. PubMed ID: 9746842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
